Bm Rhus Tox Ointment
FDA Label NDC 85816-6023

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Bm Private Limited for the product Bm Rhus Tox (NDC 85816-6023). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding inactive ingredient, otc - active ingredient, indications & usage, otc - purpose, otc - keep out of reach of children, warnings, storage and handling, contraindications, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

→ Inactive Ingredient

→ Otc - Active Ingredient

→ Indications & Usage

→ Otc - Purpose

→ Otc - Keep Out Of Reach Of Children

→ Warnings

→ Storage And Handling

→ Contraindications

→ Dosage & Administration

→ Package Label.principal Display Panel

Inactive Ingredient

CETOSTEARYL ALCOHOL, MINERAL OIL, PARAFFIN, WHITE PETROLATUM

Otc - Active Ingredient

Active ingredients (Ref. stand.) Each 40gm contains: Arnica ∅ 0.24 gm (HPUS) Bellis per ∅ 0.04 gm (HPUS) Bryonia alba D7 0.24 gm (EHPI) Camphora ∅ 0.16 gm (HPUS) Cinnamomum ∅ 0.40 gm (HPUS) Colchicum D6 0.04 gm (HPUS) Curcuma longa ∅ 0.24 gm (GHP) Rhus tox D6 0.40 gm (HPUS)

Indications & Usage

Indications: (Derived from Materia Medica by W.Boericke, 1200 Remedies by R. Murphy, Materia Media by Blackwood & authentic homoeopathic references). Help support to relieve the symptoms of joints pain and stiffness, for detail please read the enclosed package (Product information leaflet).